Register entry
- Registered sites
- 2
- Active NDC listings
- 1
- Live patents
- 0
- Countries
- 1
- Base
- Netherlands
Authorisation
Registered operations
Analytical testing1Active ingredient (API) manufacture1
Sites
Registered establishments
2| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| LMC Lysozyme Manufacturing Company B.V.Registrant: Bioseutica B.V. | Energieweg 9, Nunspeet, 8071DA, Netherlands (NLD) | Active ingredient (API) manufacture | 3015537077413955597 |
| Bioseutica B.V. | Landbouwweg 83, Zeewolde, Netherlands 3899BD, Netherlands (NLD) | Analytical testing | 3004403003489080758 |
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Lysozyme HCl | powder | 84319-103BULK INGREDIENT |
Compare
Comparable companies in Netherlands
- Eurofins BioPharma Product Testing Leiden B.V.2 sites · 0 NDC
- Fagron Services B.V.1 site · 75 NDC
- Aspen Oss B.V.1 site · 46 NDC
- Laboratorium Ofichem BV1 site · 21 NDC
- EZUF NL B.V.1 site · 17 NDC
- B.V. KATWIJK CHEMIE1 site · 13 NDC
- Dow Benelux B.V.1 site · 8 NDC
- EverZinc Nederland B.V.1 site · 4 NDC
- Niacet b.v.1 site · 2 NDC
- BioChem Oss B.V.1 site · 1 NDC
Enquiry
Common questions
- Is Bioseutica B.V. FDA approved?
- Bioseutica B.V. holds 2 FDA-registered establishments in the Netherlands. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Bioseutica B.V.'s drugs manufactured?
- The FDA register lists Nunspeet; Zeewolde. Registered operations: analytical testing, active ingredient (API) manufacture.
- What drugs does Bioseutica B.V. make?
- 1 product is listed under Bioseutica B.V. in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.